KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Treasury Shares (2016 - 2025)

Astrana Health's Treasury Shares history spans 12 years, with the latest figure at $3.8 million for Q3 2025.

  • For Q3 2025, Treasury Shares rose 26302.7% year-over-year to $3.8 million; the TTM value through Sep 2025 reached $3.8 million, up 26302.7%, while the annual FY2024 figure was $3.5 million, 67.2% down from the prior year.
  • Treasury Shares for Q3 2025 was $3.8 million at Astrana Health, up from $3.8 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $12.4 million in Q1 2021 and bottomed at $14409.0 in Q3 2024.
  • The 5-year median for Treasury Shares is $3.8 million (2025), against an average of $5.2 million.
  • The largest YoY upside for Treasury Shares was 73437.55% in 2021 against a maximum downside of 99.77% in 2021.
  • A 5-year view of Treasury Shares shows it stood at $174158.0 in 2021, then soared by 43.55% to $250000.0 in 2022, then skyrocketed by 4133.74% to $10.6 million in 2023, then increased by 0.18% to $10.6 million in 2024, then crashed by 64.12% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Treasury Shares are $3.8 million (Q3 2025), $3.8 million (Q2 2025), and $9.9 million (Q1 2025).